Heart failure & cardiomyopathies

Functional Assessment Based on Cardiopulmonary Exercise Testing in Mild Heart Failure: A Multicentre Study

ESC Heart FailPublished Cohort study

Main findingResult — go to the resultAUC 0.55 95% CI 0.51–0.59

Authors' conclusion

Patients with chronic HF classified as NYHA I overlapped substantially with those classified as NYHA II in objective physiological measures and prognosis.

Study context

Population
Consecutive heart failure (HF) patients in New York Heart Association (NYHA) class I or II undergoing cardio-pulmonary exercise test (CPET) in three Brazilian centres42% NYHA I, 58% NYHA II
Participants
688 patients
Exposure
NYHA class I vs NYHA class II
Outcome
CPET parameters by NYHA class (kernel density overlap) and discrimination by % predicted peak VO2
Methodological detailsmulticentre, consecutive patients, 3 Brazilian centres
  • Multicentre
  • Consecutive patients
  • 3 Brazilian centres

Main finding

As reported in the abstract

AUC

0.55

95% CI 0.51–0.59

P = 0.005

Kernel density overlap NYHA I vs II, % predicted peak VO2
86%
Kernel density overlap NYHA I vs II, VE/VCO2 slope
89%
Kernel density overlap NYHA I vs II, oxygen uptake efficiency slope (OUES)
84%
Absolute probability increment of NYHA I classification when % predicted peak VO2 increased from 50% to 100%
13%

Observational data: associations, not effects.

Further findings

All-cause mortality — NYHA class III patients displayed a distinctively higher death rate · not significantly different
P < 0.001 · P = 0.41

Global CPET parameters (all patients)

Median % predicted peak VO2 (IQR 56-80)
66.8%
Median VE/VCO2 slope (31.6-43.3)
36.9
Mean OUES (±0.59)
1.51

Original publication

Functional Assessment Based on Cardiopulmonary Exercise Testing in Mild Heart Failure: A Multicentre Study. ESC Heart Fail. Published 21 February 2023. doi:10.1002/ehf2.14287

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.